Our Location

304 North Cardinal St.
Dorchester Center, MA 02124


Product Name: Cabozanix

Generic Name:  Cabozantinib

Formation: Tablet

Available Pack Size: 90’s plot and 30’s plot

Strength: 20mg and 60mg

WeChat QR
WeChat QR

Cabozanix-20mg-Cabozantinib| Package Insert


Cabozanix-20mg-Cabozantinib is a drug that is used to treat specific cancers. It is an oral, small-molecule tyrosine kinase inhibitor that targets MET, VEGFR (vascular endothelial growth factor receptor), and RET, in addition to other RTKs. Cabozanix-20mg assists in preventing tumor growth, angiogenesis (the growth of new blood vessels to support the tumor), and metastasis (the spread of cancer to other parts of the body) by inhibiting these kinases.

For patients who have previously received other systemic therapies, the drug Cabozanix-20mg is approved for the treatment of several cancers, including advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). In some cases of medullary thyroid cancer, it may also be applied.

It’s important to remember that Cabozanix-20mg, like many cancer treatments, can have side effects and that its use should be carefully monitored by medical professionals. Fatigue, diarrhea, hand-foot syndrome (painful swelling or blisters on the palms of the hands and soles of the feet), hypertension (high blood pressure), and other side effects are examples of common adverse reactions.

Patients must discuss the potential advantages and disadvantages of Cabozanix-20mg with their oncologist or healthcare provider before beginning any medical procedure to choose the best course of action for their particular condition.


Cabozanix-20mg-Cabozantinib is a multi-indication cancer treatment that is indicated for the treatment of the following:

  • Nivolumab alone or in combination with single agent for the first-line treatment of advanced renal cell carcinoma (RCC).
  • Patients with hepatocellular carcinoma (HCC) who have received sorafenib treatment in the past.
  • Differentiated thyroid cancer (DTC) that is locally advanced or metastatic, has progressed after receiving prior VEGFR-targeted therapy and is radioactive iodine-resistant or ineligible for radioactive iodine therapy.

Mechanism of Action

Cabozanix-20mg-Cabozantinib is multi-kinase inhibitor that inhibits the activity of specific proteins known as receptor tyrosine kinases (RTKs) toorder to produce its desired effects. RTKs play role in several cellular functions, such as cell division, growth, and survival. Overactive RTKs can promote the growth and metastasis of cancer cells.

Cabozanix-20mg specifically inhibits the activity of the following RTKs:

  • MET
  • VEGFR1-3
  • AXL
  • RET
  • ROS1
  • TYRO3
  • MER
  • KIT
  • TRKB
  • FLT-3
  • TIE-2

By blocking the activity of these RTKs, Cabozanix-20mg can slow down or stop cancer cell growth and metastasis. It can also help shrink tumors and improve survival rates.

In addition to its direct effects on tumor cells, Cabozanix-20mg can also affect the tumor microenvironment. The tumor microenvironment is the tissue and cells that surround a tumor. It can play a role in tumor growth and metastasis. Cabozanix-20mg can help normalize the tumor microenvironment, making it more difficult for the tumor to grow and spread.

Cabozanix-20mg is a highly effective cancer treatment, but it can also cause serious side effects. The most common side effects include diarrhea, nausea, fatigue, hypertension, and hand-foot syndrome. Less common but more serious side effects can include liver damage, kidney damage, and bleeding. It is important for patients to closely monitor their symptoms and report any concerning side effects to their healthcare provider. Regular check-ups and blood tests may be necessary to monitor organ function while taking Cabozanix-20mg. In some cases, the benefits of the treatment may outweigh the potential risks, especially for patients with advanced or metastatic cancer. However, it is crucial for healthcare providers to carefully weigh the potential benefits against the risks before prescribing Cabozanix-20mg to a patient.

Dosage & Administration

Cabozanix-20mg-Cabozantinib dosage and administration depend on the cancer type and individual medical condition. Doctors determine the best dosage and schedule. For advanced renal cell carcinoma, 60 mg daily is recommended, while for hepatocellular carcinoma and DTC, 40 mg daily is recommended. Doctors may adjust dosage based on response and side effects.

Here are some general guidelines for taking Cabozanix-20mg:

  • Take Cabozanix-20mg at the same time each day.
  • You can take Cabozanix-20mg-Cabozantinib with or without food.
  • If you miss a dose of cabozantinib, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose to make up for a missed dose.
  • Swallow cabozantinib tablets whole with water. Do not chew, crush, or break the tablets.
  • Avoid taking cabozantinib with grapefruit or grapefruit juice, as this can increase the levels of cabozantinib in your blood and increase the risk of side effects.
  • Store cabozantinib tablets at room temperature, away from moisture and heat.

Side Effects of Cabozanix-20mg-Cabozantinib

Cabozanix-20mg-Cabozantinib is a drug that can have several negative side effects, such as diarrhea, nausea, vomiting, fatigue, high blood pressure, hand-foot syndrome, decreased appetite, hair loss, dry skin, mouth sores, constipation, headache, muscle pain, joint pain, difficulty sleeping, and rash. Liver damage, kidney damage, bleeding, blood clots, heart problems, lung problems, infection, seizures, and stroke are less frequent but more severe side effects. Consult your doctor for advice on how to deal with any of these side effects or how to change the dosage if you experience any of them.

Brand Name

The brand names of cabozantinib are:

  • Cometriq
  • Cabometyx

Cometriq is used to treat medullary thyroid cancer. Cabometyx is used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and locally advanced or metastatic differentiated thyroid cancer.

Price of Cabozanix-20mg-Cabozantinib

The price of cabozantinib can vary depending on the brand name, dosage, and pharmacy where you purchase it. However, it is generally a very expensive medication.

According to GoodRx, the average cost of a 30-day supply of Cabometyx 40 mg tablets is $52,576.54. The price can range from $24,943.93 to $65,157.26, depending on the pharmacy.

The generic version of this medicine is Cabozanix-20mg which is much less from the brand name medicine and effective as the brand one.

Cabozanix-20mg-Cabozantinib Success Rate:

As an AI language model, I don’t have access to real-time data or individual patient stories past my knowledge cutoff in September 2021. Additionally, sharing specific patient success stories would require accessing private and confidential information, which I don’t have.

However, it is not uncommon to find success stories or testimonials from patients who have undergone cabozantinib treatment for various types of cancer. Some patients may experience significant tumor shrinkage, improved quality of life, and extended survival rates due to the effectiveness of cabozantinib in treating their specific condition.

Cabozanix-20mg-Cabozantinib Life Expectancy

Cabozantinib’s life expectancy varies based on the cancer type and individual condition. However, it has been shown to improve survival rates in various cancers. In a clinical trial, it increased median overall survival in patients with advanced renal cell carcinoma, extended it in those with hepatocellular carcinoma who had previously received sorafenib, and extended it in patients with locally advanced or metastatic differentiated thyroid cancer who had progressed after prior VEGFR-targeted therapy.

See our other medicine Axinix-5mg, Palbonix100/125mg, Ibrutix-140mg, Bevixa.

Read the Blog on our site PARP inhibitors an ovarian and breast cancer treatment.

Visit our Facebook Page to get latest update about Oncology medicine.

What are the side effects of Cabozantinib?
As with any medication, Cabozanix-20mg can cause side effects. Common side effects may include: Fatigue Diarrhea Nausea Decreased appetite Hand-foot syndrome (painful swelling or blisters on the palms of the hands and soles of the feet) High blood pressure (hypertension) Vomiting Constipation Mouth sores Abdominal pain Headache Muscle pain Joint pain Skin rashes It's important to note that individual reactions to the medication may vary, and some patients may experience different or more severe side effects. Patients should promptly report any concerning or persistent side effects to their healthcare provider for proper evaluation and management.
What is Cabozantinib mechanism of action?
Cabozanix-20mg is a tyrosine kinase inhibitor that works by blocking multiple receptor tyrosine kinases (RTKs) involved in cancer growth and progression. It inhibits the activity of MET, VEGFR, and RET, which are proteins involved in signaling pathways that promote tumor growth, angiogenesis, and metastasis. Specifically, Cabozanix-20mg binds to the ATP-binding site of these RTKs, preventing them from phosphorylating (activating) downstream targets. This disruption in signaling pathways ultimately leads to decreased tumor cell proliferation, reduced formation of new blood vessels to support the tumor (angiogenesis), and inhibition of cancer spread to other parts of the body (metastasis). By targeting multiple pathways simultaneously, Cabozanix-20mg can have a broader impact on cancer cells, making it a valuable treatment option for certain types of cancer.
How quickly does cabozantinib work?
The speed at whichCabozanix-20mg starts to work can vary from patient to patient and depends on several factors, including the type and stage of the cancer being treated. Some patients may experience a response to the medication within a few weeks, while others may take several months to show significant improvement. It's essential to understand that cancer treatments, including Cabozanix-20mg, require time to exert their effects on tumor growth and may require continued treatment to achieve optimal results. Regular monitoring and follow-up with healthcare providers are crucial to assess the treatment's effectiveness and adjust the therapy as needed.
Is cabozantinib chemotherapy?
No, Cabozanix-20mg is not a traditional chemotherapy drug. It is classified as a targeted therapy and specifically falls under the category of tyrosine kinase inhibitors (TKIs). While both chemotherapy and Cabozanix-20mg aim to treat cancer, they work through different mechanisms. Chemotherapy involves the use of drugs that target rapidly dividing cells, including cancer cells, but it can also affect healthy cells, leading to various side effects. On the other hand, Cabozanix-20mg is a targeted therapy that specifically targets certain receptor tyrosine kinases involved in cancer growth, minimizing the impact on healthy cells and potentially reducing some of the side effects associated with traditional chemotherapy.
How does cabozantinib work?
Cabozanix-20mg works as a tyrosine kinase inhibitor by targeting and inhibiting multiple receptor tyrosine kinases (RTKs), including MET, VEGFR (vascular endothelial growth factor receptor), and RET. These RTKs play crucial roles in promoting tumor growth, angiogenesis (formation of new blood vessels to support the tumor), and metastasis (spread of cancer to other parts of the body).By inhibiting these RTKs, Cabozanix-20mg disrupts the signaling pathways that contribute to cancer cell proliferation and survival, prevents the formation of new blood vessels that support tumor growth, and reduces the spread of cancer cells to other tissues. This targeted approach makes cabozantinib effective in certain types of cancers that rely on these specific signaling pathways for their growth and progression.
How effective is cabozantinib?
The effectiveness of Cabozanix-20mg varies depending on the type of cancer being treated and the individual patient's response to the medication. Clinical studies have demonstrated significant benefits for certain cancers, such as advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer), particularly in patients who have previously received other treatments. In clinical trials, Cabozanix-20mg has shown efficacy in terms of tumor response, progression-free survival (the time during which the disease does not worsen), and overall survival in certain patient populations. However, the response to Cabozanix-20mg can differ among patients, and not all individuals will experience the same level of benefit. As with any cancer treatment, the effectiveness of Cabozanix-20mg may be influenced by various factors, including the stage of the disease, the extent of metastasis, and individual patient characteristics.
How long does cabozantinib work?
The duration of cabozantinib's effectiveness can vary from patient to patient and depends on how well the medication controls cancer's growth and spread. Some patients may experience prolonged periods of disease control and benefit from Cabozanix-20mg for an extended period, while others may eventually develop resistance to the drug, leading to disease progression.


There are no reviews yet.

Be the first to review “Cabozanix-20mg-Cabozantinib”